EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Focal Cortical Dysplasia Type II : Somatic Mutations, Molecular Mechanisms, and Integrative Multi‐Omics Framework

Zesheng Li iD, Yihe Wang iD, Jianwei Shi iD, Yumin Luo iD, Yongzhi Shan iD, Guoguang Zhao iD

CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)

DOI: 10.1002/cns.71170 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 23.09.2026. Verfasst von Zesheng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Mutation, Focal Cortical Dysplasia, Malformations of Cortical Development, Group I. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science & Technology Commission, Beijing Natural Science Foundation-Daxing Innovation Joint Fund, Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Focal cortical dysplasia Type II (FCD II) is a major cause of drug‐resistant epilepsy in children. Somatic mosaic variants affecting the PI3K–AKT–mTOR pathway are implicated in a substantial proportion of cases. The links between genotype, cellular pathology, epileptogenic networks, and clinical outcome remain incompletely defined.

Methods

This review synthesizes evidence on somatic mTOR–pathway variants, lesion development, pathological cell populations, circuit mechanisms, single‐cell and spatial multi‐omics approaches in FCD II.

Results

The developmental timing, lineage distribution, and local expansion of somatic variants influence lesion extent and phenotypic heterogeneity. Dysmorphic neurons may contribute to epileptogenicity through altered intrinsic excitability and synaptic function, whereas balloon cells may predominantly affect local circuits through secretory and microenvironmental mechanisms. mTOR hyperactivation may also alter interneuron development, subtype specification, and synaptic connectivity, thereby disrupting excitation‐inhibition balance. Single‐cell and spatial approaches, including RNA velocity, pseudotime analysis, chromatin‐age inference, and somatic genotyping, provide tools to resolve pathological cell states and lineage trajectories.

Conclusions

FCD II should be considered a mosaic developmental disorder involving both cell‐autonomous and non‐cell‐autonomous mechanisms. Integrating somatic variant detection with cellular, spatial, electrophysiological, and surgical outcomes from matched patient tissue may enable biologically meaningful stratification and support the development of novel therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationFocal Cortical DysplasiaMalformations of Cortical Development, Group IHumansAnimalsMultiomicsTOR Serine-Threonine KinasesSignal Transduction

Stichwörter der Autor:innen

epileptogenic networkfocal cortical dysplasiamTOR signalingsingle‐cell genomicssomatic mutation

Substanzen

TOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Clinical Research Center for Epilepsy, Capital Medical University, Beijing, China.
  • China International Neuroscience Institute, Beijing, China.

ORCID-Profile: Zesheng Li, Yihe Wang, Jianwei Shi, Yumin Luo, Yongzhi Shan, Guoguang Zhao

Förderung

  • Beijing Municipal Science & Technology Commission
  • Beijing Natural Science Foundation-Daxing Innovation Joint Fund
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park

Zitieren

APA

Li, Z., Wang, Y., Shi, J., Luo, Y., Shan, Y., & Zhao, G. (2026). Focal Cortical Dysplasia Type II : Somatic Mutations, Molecular Mechanisms, and Integrative Multi‐Omics Framework. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71170

Vancouver

Li Z, Wang Y, Shi J, Luo Y, Shan Y, Zhao G. Focal Cortical Dysplasia Type II : Somatic Mutations, Molecular Mechanisms, and Integrative Multi‐Omics Framework. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71170

BibTeX
@article{Li2026,
  author = {Li, Zesheng and Wang, Yihe and Shi, Jianwei and Luo, Yumin and Shan, Yongzhi and Zhao, Guoguang},
  title = {Focal Cortical Dysplasia Type II : Somatic Mutations, Molecular Mechanisms, and Integrative Multi‐Omics Framework},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {9},
  doi = {10.1002/cns.71170}
}
Kostenlos starten →